During the past decade, Universitätsklinikum Regensburg, Klinik & Poliklinik für Augenheilkunde conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Regensburg, Klinik & Poliklinik für Augenheilkunde" are "Geographic Atrophy" (3 trials) and "Neovascular Age-related Macular Degeneration (nAMD)" (1 trials). Many other conditions were trialed in "Universitätsklinikum Regensburg, Klinik & Poliklinik für Augenheilkunde" in a lesser frequency.

Most popular intervention types in "Universitätsklinikum Regensburg, Klinik & Poliklinik für Augenheilkunde" are "Drug" (3 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Lampalizumab" (2 trials), "No intervention" (1 trials), "Port Delivery System with Ranibizumab" (1 trials), "Ranibizumab" (1 trials) and "Sham Comparator" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsklinikum Regensburg, Klinik & Poliklinik für Augenheilkunde" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Universitätsklinikum Regensburg, Klinik & Poliklinik für Augenheilkunde". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Universitätsklinikum Regensburg, Klinik & Poliklinik für Augenheilkunde, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsklinikum Regensburg, Klinik & Poliklinik für Augenheilkunde, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".